Literature DB >> 3007971

Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3007971

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  4 in total

Review 1.  Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Authors:  H M Chapel
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 2.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

Review 3.  Immunoglobulin therapy in immunohematological disorders.

Authors:  V P Choudhry; M Mahapatra; R Kashyap
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

4.  Lack of HIV transmission after hepatitis B immunoprophylaxis.

Authors:  J Genescà; J I Esteban; R Esteban; J M Hernández; J Guardia
Journal:  Infection       Date:  1987       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.